TBPH · ISSUER CIK 1583107
Theravance Biopharma, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 11 Theravance Biopharma, Inc. insiders reported $0.00 of open-market purchases and $227K of sales on SEC Form 4.
↗11 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$227KInsider selling
−$227KNet open-market
Sep 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 202615:20 | Sep 23, 2026 | TBPH | Former 10% Owner · +2 joint | J · OtherLate 5d | $17.00 | −7,457,060 | 0 | -100% | $126.8M | ||
| Sep 24, 202620:37 | Sep 23, 2026 | TBPH | Director | D · To issuer | — | −64,074 | 0 | -100% | — | ||
| Sep 24, 202620:36 | Sep 23, 2026 | TBPH | Director | D · To issuer | — | −80,213 | 0 | -100% | — | ||
| Sep 24, 202620:32 | Sep 23, 2026 | TBPH | Director | D · To issuer | — | −97,213 | 0 | -100% | — | ||
| Sep 24, 202620:31 | Sep 23, 2026 | TBPH | Director | D · To issuer | — | −48,146 | 0 | -100% | — | ||
| Sep 24, 202620:29 | Sep 23, 2026 | TBPH | Director | D · To issuer | — | −80,989 | 0 | -100% | — | ||
| Sep 24, 202620:27 | Sep 23, 2026 | TBPH | CHIEF EXECUTIVE OFFICER, Director | D · To issuer | — | −1,726,989 | 0 | -100% | — | ||
| Sep 24, 202620:25 | Sep 23, 2026 | TBPH | SVP & CHIEF FINANCIAL OFFICER | D · To issuer | — | −336,841 | 0 | -100% | — | ||
| Sep 24, 202620:24 | Sep 23, 2026 | TBPH | SVP, DEV & HEAD OF IRE OFFICE | D · To issuer | — | −189,826 | 0 | -100% | — | ||
| Sep 24, 202620:23 | Sep 23, 2026 | TBPH | SVP, GEN COUNSEL AND SECRETARY | D · To issuer | — | −355,168 | 0 | -100% | — | ||
| Sep 24, 202620:21 | Sep 23, 2026 | TBPH | SVP, COMM & MEDICAL AFFAIRS | D · To issuer | — | −213,476 | 0 | -100% | — | ||
| Sep 17, 202617:52 | Sep 15, 2026 | TBPH | SVP, COMM & MEDICAL AFFAIRS | S · Sell10b5-1 | $17.03 | −13,314 | 213,476 | -6% | −$227K | ||
| Aug 24, 202618:09 | Aug 20, 2026 | TBPH | CHIEF EXECUTIVE OFFICER, Director | F · Tax | $16.95 | −20,034 | 1,611,022 | -1% | $340K | ||
| Aug 24, 202618:07 | Aug 20, 2026 | TBPH | SVP & CHIEF FINANCIAL OFFICER | F · Tax | $16.95 | −8,112 | 336,841 | -2% | $137K | ||
| Aug 24, 202618:04 | Aug 20, 2026 | TBPH | SVP, DEV & HEAD OF IRE OFFICE | F · Tax | $16.95 | −6,258 | 189,826 | -3% | $106K | ||
| Aug 24, 202618:02 | Aug 20, 2026 | TBPH | SVP, GEN COUNSEL AND SECRETARY | F · Tax | $16.95 | −7,952 | 355,168 | -2% | $135K | ||
| Aug 24, 202618:00 | Aug 20, 2026 | TBPH | SVP, COMM & MEDICAL AFFAIRS | F · Tax | $16.95 | −5,667 | 226,790 | -2% | $96K |